|
¿À±¹È¯ ±³¼ö
|
°û ö ±³¼ö
|
°Àç½Â ±³¼ö
|
¼¿ï´ëº´¿ø ³»°ú ¿À±¹È¯ ±³¼ö, ºñ´¢±â°ú °û ö ±³¼ö, ¼¿ïÀÇ´ë ÇغÎÇб³½Ç °Àç½Â ±³¼ö°¡ 5ÀÏ °úÇбâ¼ú¿ì¼ö³í¹®»ó'À» ¼ö»óÇß´Ù.
À̳¯ ÀÌµé ±³¼ö´Â ¼¿ï ÄÚ¿¢½º¿¡¼ ¿¸° ‘2012³âµµ ´ëÇѹα¹°úÇбâ¼ú¿¬Â÷´ëȸ’¿¡¼ ±³À°°úÇбâ¼úºÎ¿Í Çѱ¹°úÇбâ¼ú´ÜüÃÑ¿¬ÇÕȸ°¡ ½Ã»óÇÏ´Â 'Á¦22ȸ °úÇбâ¼ú¿ì¼ö³í¹®»ó'À» ¹Þ¾Ò´Ù.
°úÇбâ¼ú¿ì¼ö³í¹®»óÀº Çѱ¹°úÇбâ¼ú´ÜüÃÑ¿¬ÇÕȸ°¡ Áö³ ÇÑ ÇØ µ¿¾È ÀǾàÇкоߴ ¹°·Ð, °øÇÐ, ÀÚ¿¬°úÇÐ µî °úÇÐ Àü ºÐ¾ß¿¡¼ ¹ßÇ¥µÈ ³í¹®µé Áß °¢ 1Æí¾¿À» Çùȸ »êÇÏ ÃÑ 368°³ ÇÐȸ·ÎºÎÅÍ ÃßõÀ» ¹Þ¾Æ ¾ö°ÝÇÑ ½É»ç¸¦ °ÅÃÄ ¼±Á¤µÈ ¼ö»óÀÚ¿¡°Ô ¼ö¿©µÈ´Ù.
¿À±¹È¯ ±³¼ö´Â Àå±â°£ º¹¸·Åõ¼®À» ½ÃÇà ¹ÞÀº ȯÀÚ¿¡°Ô¼ ³ªÅ¸³ª´Â º¯¼º Çö»óÀ» Á¶Á÷ ³»¿¡¼ aquaporin°ú VEGF/VEGF receptor ¹°ÁúÀÇ º¯È¸¦ ÅëÇØ ±Ô¸íÇÑ “Expression of Aquaporin-1, Vascular Endothelial Growth Factor and Vascular Endothelial Growth Factor Receptor-1 in the Peritoneal Tissues of Peritoneal Dialysis Patients”¶õ ³í¹®À» ¹ßÇ¥, ¼ö»óÀÚ°¡ µÆ´Ù.
°û ö ±³¼ö´Â ¹æ±¤¾Ï¿¡¼ À¯ÀüÀÚº¯Çü Ç÷°ü³»ÇǼ¼Æ÷¸¦ ÀÌ¿ëÇÑ Ç׾Ϲé½Å°ú GM-CSFÀÇ Åõ¿©°¡ ¹æ±¤¾ÏÀÇ ½Å»ýÇ÷°üÇü¼ºÀ» ¾ïÁ¦ÇÔÀ¸·Î½á Ç×¾ÏÈ¿°ú¸¦ °¡Áø´Ù´Â »ç½ÇÀ» ¹àÇô³ÂÀ¸¸ç À̸¦ imatinibÀ̶ó´Â ¾à¹°°ú º´ÇÕ½ÃÄÑ »ç¿ëÇÏ¸é »ó½ÂÈ¿°ú¸¦ °®´Â´Ù´Â "Combined treatment with anticancer vaccine using genetically modified endothelial cells and imatinib in bladder cancer"¶ó´Â ³í¹®À» ¹ßÇ¥, °ø·Î°¡ ÀÎÁ¤µÆ´Ù.
°Àç½Â ±³¼ö´Â Áö³ 1999³âºÎÅÍ ¿ì¸® ¸ö¿¡¼ ¿°Áõ¹ÝÀÀÀ» ÀÏÀ¸ÄÑ Á¾¾ç ¹ß»ý°ú ¼ºÀå¿¡ °ü¿©ÇÏ´Â °ÍÀ¸·Î »ý°¢µÇ´Â CM1À̶ó´Â ¹°Áú ±Ô¸í¿¡ ³ª¼ Æ÷µµ´ç´ë»ç °úÁ¤ Áß¿¡ ÀÛ¿ëÇÏ´Â Áß¿äÇÑ È¿¼Ò ¿¡³î·¹ÀÌÁî(enolase)ÀÎ °ÍÀ» "Identification of CM1 as a pathogenic factor in inflammatory diseases and cancer"¶ó´Â ³í¹®À» ÅëÇØ ¹ßÇ¥ÇÑ °ø·Î°¡ ÀÎÁ¤µÆ´Ù